BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16086382)

  • 1. Identification of an X-linked locus modifying mouse skin tumor susceptibility.
    George K; Iacobucci A; Uitto J; O'Brien TG
    Mol Carcinog; 2005 Nov; 44(3):212-8. PubMed ID: 16086382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic control of polyamine-dependent susceptibility to skin tumorigenesis.
    Megosh LC; Hu J; George K; O'Brien TG
    Genomics; 2002 Apr; 79(4):505-12. PubMed ID: 11944982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of C57Bl/6 mice from a tumor promotion-resistant to a -sensitive phenotype by enhanced ornithine decarboxylase expression.
    Guo Y; Zhao J; Sawicki J; Peralta Soler A; O'Brien TG
    Mol Carcinog; 1999 Sep; 26(1):32-6. PubMed ID: 10487519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analyses of mouse skin tumor progression susceptibility using SENCAR inbred derived strains.
    Stern MC; Benavides F; LaCava M; Conti CJ
    Mol Carcinog; 2002 Sep; 35(1):13-20. PubMed ID: 12203363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of intercross outbred mice and single nucleotide polymorphisms to map skin cancer modifier loci.
    Peissel B; Zaffaroni D; Pazzaglia S; Manenti G; Zanesi N; Zedda I; Rebessi S; Covelli V; Dragani TA; Saran A
    Mamm Genome; 2001 Apr; 12(4):291-4. PubMed ID: 11309660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel genetic loci contributing to 12-O-tetradecanoylphorbol-13-acetate skin tumor promotion susceptibility in DBA/2 and C57BL/6 mice.
    Angel JM; Caballero M; DiGiovanni J
    Cancer Res; 2003 Jun; 63(11):2747-51. PubMed ID: 12782578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allele-specific Hras mutations and genetic alterations at tumor susceptibility loci in skin carcinomas from interspecific hybrid mice.
    Nagase H; Mao JH; Balmain A
    Cancer Res; 2003 Aug; 63(16):4849-53. PubMed ID: 12941805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of the Pas1 and Par2 genes in determination of the unique, intermediate susceptibility of BALB/cByJ mice to urethane-induction of lung carcinogenesis: differential effects on tumor multiplicity, size and Kras2 mutations.
    Karasaki H; Obata M; Ogawa K; Lee GH
    Oncogene; 1997 Oct; 15(15):1833-40. PubMed ID: 9362450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple genetic loci modify susceptibility to plasmacytoma-related morbidity in E(mu)-v-abl transgenic mice.
    Symons RC; Daly MJ; Fridlyand J; Speed TP; Cook WD; Gerondakis S; Harris AW; Foote SJ
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11299-304. PubMed ID: 12149518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. At least four loci and gender are associated with susceptibility to the chemical induction of lung adenomas in A/J x BALB/c mice.
    Festing MF; Lin L; Devereux TR; Gao F; Yang A; Anna CH; White CM; Malkinson AM; You M
    Genomics; 1998 Oct; 53(2):129-36. PubMed ID: 9790761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epistatic interactions between skin tumor modifier loci in interspecific (spretus/musculus) backcross mice.
    Nagase H; Mao JH; de Koning JP; Minami T; Balmain A
    Cancer Res; 2001 Feb; 61(4):1305-8. PubMed ID: 11245425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the Par2 (Pulmonary adenoma resistance) locus on mouse chromosome 18, a major genetic determinant for lung carcinogen resistance in BALB/cByJ mice.
    Obata M; Nishimori H; Ogawa K; Lee GH
    Oncogene; 1996 Oct; 13(8):1599-604. PubMed ID: 8895504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haploinsufficiency for odc modifies mouse skin tumor susceptibility.
    Guo Y; Cleveland JL; O'Brien TG
    Cancer Res; 2005 Feb; 65(4):1146-9. PubMed ID: 15734996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic modifier loci of transplanted SP2/0 tumors in mice].
    Ji LL; Qian XW; Tan XL
    Ai Zheng; 2008 Jul; 27(7):703-9. PubMed ID: 18606062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide association and fine mapping of genetic loci predisposing to colon carcinogenesis in mice.
    Liu P; Lu Y; Liu H; Wen W; Jia D; Wang Y; You M
    Mol Cancer Res; 2012 Jan; 10(1):66-74. PubMed ID: 22127497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loci of intestinal distress in cystic fibrosis knockout mice.
    Haston CK; Tsui LC
    Physiol Genomics; 2003 Jan; 12(2):79-84. PubMed ID: 12441405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin.
    Guo H; Miao H; Gerber L; Singh J; Denning MF; Gilliam AC; Wang B
    Cancer Res; 2006 Jul; 66(14):7050-8. PubMed ID: 16849550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distal Chr 4 harbors a genetic locus (Gct1) fundamental for spontaneous ovarian granulosa cell tumorigenesis in a mouse model.
    Dorward AM; Shultz KL; Horton LG; Li R; Churchill GA; Beamer WG
    Cancer Res; 2005 Feb; 65(4):1259-64. PubMed ID: 15735010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel modifier loci of Apc Min affecting mammary tumor development.
    Wang H; Teske D; Tess A; Kohlhepp R; Choi Y; Kendziorski C; Moser AR
    Cancer Res; 2007 Dec; 67(23):11226-33. PubMed ID: 18056448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A locus that influences susceptibility to 1, 2-dimethylhydrazine-induced colon tumors maps to the distal end of mouse chromosome 3.
    Angel JM; Popova N; Lanko N; Turusov VS; DiGiovanni J
    Mol Carcinog; 2000 Jan; 27(1):47-54. PubMed ID: 10642436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.